Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 663,302 | 570,721 | 451,723 | 456,811 | 298,139 |
| Marketable Securities | N/A | 1,134,989 | 1,154,071 | 949,239 | 978,473 |
| Receivables | 753,611 | 686,848 | 661,519 | 683,841 | 684,242 |
| Inventories | 506,557 | 447,373 | 392,936 | 362,940 | 337,619 |
| Other current assets | 3,405,368 | 404,406 | 395,139 | 416,088 | 379,477 |
| TOTAL | $5,328,838 | $3,244,337 | $3,055,388 | $2,868,919 | $2,677,950 |
| Non-Current Assets | |||||
| PPE Net | 1,736,811 | 1,742,200 | 1,676,583 | 1,622,812 | 1,617,459 |
| Investments And Advances | 306,839 | 2,310,712 | 2,012,678 | 1,739,773 | 1,840,880 |
| Intangibles | 2,792,229 | 2,832,843 | 2,885,972 | 2,930,876 | 2,977,260 |
| TOTAL | $4,835,879 | $6,885,755 | $6,575,233 | $6,293,461 | $6,435,599 |
| Total Assets | $10,164,720 | $10,130,120 | $9,630,621 | $9,162,380 | $9,113,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 165,207 | 203,999 | 157,424 | 159,152 | 173,330 |
| Accrued Expenses | 885,093 | 979,945 | 866,208 | 762,353 | 660,562 |
| TOTAL | $1,281,662 | $1,657,389 | $1,521,093 | $1,432,865 | $1,337,319 |
| Non-Current Liabilities | |||||
| Long Term Debt | 711,831 | 687,396 | 658,442 | 641,568 | 626,012 |
| Other Non-Current Liabilities | 674,951 | 604,266 | 539,569 | 534,063 | 517,701 |
| TOTAL | $1,543,449 | $1,508,934 | $1,447,588 | $1,458,830 | $1,467,682 |
| Total Liabilities | $2,825,111 | $3,166,323 | $2,968,681 | $2,891,695 | $2,805,001 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 237,375 | 236,312 | 236,597 | 236,347 | 239,563 |
| Common Shares | 128 | 127 | 127 | 127 | 129 |
| Retained earnings | 4,913,543 | 4,486,794 | 4,194,551 | 3,796,154 | 3,409,308 |
| Other shareholders' equity | -67,020 | -52,651 | -48,801 | -48,243 | -15,137 |
| TOTAL | $7,339,606 | $6,963,795 | $6,661,940 | $6,270,685 | $6,308,548 |
| Total Liabilities And Equity | $10,164,717 | $10,130,118 | $9,630,621 | $9,162,380 | $9,113,549 |